The antiangiogenic properties of thalidomide that caused birth defects when the drug was given to pregnant women have led to an interest in its potential therapeutic applications. Researchers at the de Duve Institute, Université catholique de Louvain, reported promising results from a case study of thalidomide therapy in patients with severe arteriovenous malformations. The study demonstrated a striking reduction in symptoms, and improved quality of life for patients treated using thalidomide.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed